Levetiracetam dosing in patients receiving continuous renal replacement therapy,Epilepsia

当前位置： X-MOL 学术 › Epilepsia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Levetiracetam dosing in patients receiving continuous renal replacement therapy
Epilepsia ( IF 6.6 ) Pub Date : 2021-07-11 , DOI: 10.1111/epi.16971
Weerachai Chaijamorn ₁ , Taniya Charoensareerat ₁ , Dhakrit Rungkitwattanakul ₂ , Sathian Phunpon ₁ , Thanompong Sathienluckana ₁ , Nattachai Srisawat _{3,

4,

5,

6,

7,

8} , Sutthiporn Pattharachayakul ₉

Affiliation

The study was aimed to define appropriate levetiracetam dosing regimens from available published pharmacokinetics (PK) studies in critically ill patients with and without cirrhosis receiving continuous renal replacement therapy (CRRT) via Monte Carlo simulation (MCS).

中文翻译：